BKYI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BIO-Key International Inc (BKYI) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows weak financial performance, no clear technical signals, and lacks positive catalysts to drive significant growth in the near term. Given the investor's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in this stock for now.
The MACD is slightly positive but contracting, indicating a lack of strong momentum. RSI is neutral at 41.251, and moving averages are converging, showing no clear trend. The stock is trading below its pivot level (0.622) and closer to its support level (S1: 0.567), suggesting bearish sentiment.
The company anticipates breakeven and profitability in 2026, which could be a long-term positive catalyst if achieved.
The company received a Nasdaq notice for a filing delay, which raises concerns about operational efficiency. Revenue dropped significantly (-27.75% YoY) in the latest quarter, and EPS declined sharply (-61.54% YoY).
In Q3 2025, revenue dropped by 27.75% YoY to $1,549,706. Net income improved slightly (-30.57% YoY), but the company remains unprofitable. EPS fell significantly (-61.54% YoY), and gross margin declined slightly (-1.80% YoY). Overall, the financials indicate weak performance.
No analyst rating or price target data available.
